Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseLeasesOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Orchestra BioMed Holdings (OBIO) Preferred Shares Issued (2022)

Orchestra BioMed Holdings (OBIO) has disclosed Preferred Shares Issued for 1 consecutive years, with $42.5 million as the latest value for Q3 2022.

  • On a quarterly basis, Preferred Shares Issued changed N/A to $42.5 million in Q3 2022 year-over-year; TTM through Dec 2022 was $109.8 million, a N/A change, with the full-year FY2022 number at $109.8 million, changed N/A from a year prior.
  • Preferred Shares Issued was $42.5 million for Q3 2022 at Orchestra BioMed Holdings, up from $40.0 million in the prior quarter.
  • In the past five years, Preferred Shares Issued ranged from a high of $42.5 million in Q3 2022 to a low of $27.3 million in Q1 2022.